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Abstract. hDlg, a human homologue of the Drosophila 
Dig tumor suppressor, contains two binding sites for 
protein 4.1, one within a domain containing three PSD- 
95/DIg/ZO-1 (PDZ) repeats and another within the al- 
ternatively spliced I3 domain. Here, we further define 
the PDZ-protein 4.1 interaction in vitro and show the 
functional role of both 4.1 binding sites in situ. A single 
protease-resistant structure formed by the entirety of 
both PDZ repeats 1 and 2 (PDZ1-2) contains the pro- 
tein 4.1-binding site. Both this PDZ1-2 site and the 13 
domain associate with a 30-kD NH2-terminal domain of 
protein 4.1 that is conserved in ezrin/radixin/moesin 
(ERM) proteins. We show that both protein 4.1 and the 
ezrin ERM protein interact with the murine form of 
hDlg in a coprecipitating immune complex. In perme- 
abilized cells and tissues, either the PDZ1-2 domain or 
the 13 domain alone are sufficient for proper subcellu- 
lar targeting of exogenous hDlg. In situ, PDZ1-2-medi- 
ated targeting involves interactions with both 4.1/ERM 
proteins and proteins containing the COOH-terminal 
T/SXV motif. I3-mediated targeting depends exclu- 
sively on interactions with 4.1/ERM proteins. Our data 
elucidates the multivalent nature of membrane-associ- 
ated guanylate kinase homologue (MAGUK) target- 
ing, thus beginning to define those protein interactions 
that are critical in MAGUK function. 
I~  HE human homologue of the Drosophila discs-large 
1  |  (dig)  tumor suppressor protein (hDlg;  Lue et al., 
1994), is a member of a superfamily known as mem- 
brane-associated guanylate kinase homologues (MAGUKs) 
(Woods and Bryant, 1993). The amino acid sequence of 
hDlg includes a  core  arrangement of several domains 
conserved in other MAGUK proteins: a domain that is 
homologous to the known guanylate kinases (GUK), a Src 
Homology domain 3 (SH3) motif, and three repetitive se- 
quence motifs known as PSD-95/Dlg/ZO-1 (PDZ) repeats. 
PDZ sequences (Kennedy, 1995) have previously been de- 
scribed as GLGF repeats (Cho et al., 1992) and Dig Homol- 
ogy region domains (Bryant et al., 1993). The MAGUK su- 
perfamily currently consists of three subgroups distinguished 
by size and variations in their domain organization (Fig. 1). 
While the PDZ-SH3-GUK core arrangement is well con- 
served among family members, several proteins contain 
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additional sequences  that are probably essential  to their 
differing cellular functions. For example, hDlg contains an 
NH2-terminal domain that is not found in other MAGUKs 
(Lue et al., 1994), and ZO-1 (Itoh et al., 1993; Willot et al., 
1993) and  ZO-2  (Jesaitis  and  Goodenough, 1994) both 
contain unique COOH-terminal domains. More recently, 
a rat neuronal homologue of hDlg (SAP97; Muller et al., 
1995) has also been shown to contain the additional se- 
quence domains characteristic  of the human protein. The 
observation that recessive mutations in the Drosophila dlg 
locus  lead  to  imaginal disc  neoplasia  and  larval  death 
(Woods and Bryant, 1991) implies that MAGUK proteins 
have a role in growth control. Aberrant cell adhesion in 
dig mutants also suggests that MAGUKs provide a func- 
tional link between growth regulation and cell-cell con- 
tact.  More recently, the Caenorhabditis elegans LIN-2A 
MAGUK has been shown to have a role in vulval induc- 
tion upstream of LET-60 Ras (Horvitz and Sulston,  1980; 
Ferguson and Horvitz, 1985; Hoskins et al., 1996). 
In spite of the mutant studies in Drosophila and C. ele- 
gans, little is known about either the biochemical activities 
or in vivo function of MAGUK proteins. An early hypoth- 
esis of MAGUK function focused on the enzymatic activ- 
ity of the GUK domain found in all of the known family 
members.  This was partly based on the observation that 
Drosophila dlg mutants with deletions in the GUK do- 
main displayed the mutant phenotype (Woods and Bryant, 
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tion of the  MAGUK super- 
family, hDlg, Drosophila Dig 
(Woods  and  Bryant,  1991), 
the  rat  synaptic  protein, 
PSD-95 (Cho et al., 1992; Kist- 
ner et al., 1993), the mamma- 
lian  tight  junction  proteins, 
ZO-1 (Itoh et al., 1993; Willot 
et al., 1993), and ZO-2 (Jesai- 
tis  and  Goodenough,  1994), 
comprise  the  Group  I 
MAGUK proteins.  Dig  and 
PSD-95  consist  entirely  of 
the  core  arrangement  of 
three  PDZ  repeats,  an  SH3 
motif, and the GUK domain. 
hDlg has an additional NH2- 
terminal  domain  that  is  not 
found in other MAGUK pro- 
teins,  and  ZO-1  and  ZO-2 
each  include  an  additional 
COOH-terminal  domain.  A 
rat  neuronal  form  of  hDlg 
termed SAP97 (Muller et al. 
1995)  and  human  ZO-2 
(Montermini  et  al.,  1995) 
have  also  been  identified. 
The human erythrocyte pro- 
tein,  p55  (Ruff et al.,  1991), 
and the human DLG2 and DLG3 gene products (Mazoyer et al., 1995; these sequence data are available from GenBank/EMBL/NDBJ 
under accession number U37707.) comprise the group II MAGUK proteins. Group II proteins have the same arrangement of conserved 
domains found in group I but contain only a single incomplete PDZ repeat. Group III MAGUK proteins include the C. elegans lin-2 
gene product (Hoskins et al., 1996) and the rat neuronal CASK protein (Hata et al., 1996). Members of this subgroup are most similar to 
group II proteins but contain an additional NH2-terminal domain homologous to the calmodulin-dependent protein kinases (CaMKll). 
The PDZ repeats, SH3, and guanylate kinase domains are labeled.  The three alternatively  spliced sequence domains found in hDlg are 
indicated at the approximate positions of their insertion into the known eDNA sequence. The length of each cartoon is proportional to 
each protein's size. 
1991) and the logic of an enzymatic domain having a role 
in signal transduction.  But guanylate kinase enzymatic ac- 
tivity has yet to be demonstrated  for any MAGUK  pro- 
tein,  and point mutagenesis of the LIN-2A GUK domain 
does not affect vulval development (Hoskins et al., 1996). 
Therefore,  more  serious  consideration  must  be  given  to 
the  possibility  that  MAGUKs  have  an  important  struc- 
tural  role in the cytoskeleton and that their location  and 
binding interactions are central to their function. 
All  MAGUK  proteins  localize  to  specific  cytoplasmic 
domains of the plasma membrane, hDlg localizes to the in- 
ner face of the membrane at regions of intercellular  con- 
tact (Lue et al.,  1994), while Dig, ZO-1, and ZO-2 are lo- 
cated  at  occluding cell junctions  (Stevenson  et  al.,  1986; 
Gumbiner  et  al.,  1991; Woods and Bryant,  1991; Jesaitis 
and Goodenough, 1994). To understand how the subcellu- 
lar  localization  of MAGUK  proteins  can  play  a  role  in 
their  function,  one  must  identify  the  molecular  basis  of 
such targeting. The demonstration that both p55 and hDlg 
bind to cytoskeletal protein 4.1 in vitro offered the first ex- 
planation of how MAGUK proteins could directly associ- 
ate with  specific submembrane  protein  complexes  (Lue 
et al., 1994; Marfatia et al., 1994). Here we show that a sin- 
gle protease-resistant  structure  formed by both PDZ  re- 
peats  1 and 2  (PDZ1-2) forms a  single folded conforma- 
tional  unit  that  constitutes  a  protein  4.1-binding  site.  A 
second protein 4.1-binding site lies within  the I3 domain 
and is restricted  to a  subset  of alternatively  spliced hDlg 
isoforms.  Since  both  sites  on hDlg bind  within  the  con- 
served 30-kD NH2-terminal domain of protein 4.1, the as- 
sociation  between  hDlg  and  the  cytoskeleton  should  in- 
clude  interactions  with  other  4.1-related  proteins.  We 
show that hDlg is part of a complex that includes direct in- 
teractions with both protein 4.1  and the ezrin ERM pro- 
tein. Either PDZ1-2 or 13 is sufficient for proper submem- 
brane targeting in cells. The targeting of PDZ1-2 depends 
on both  threonine/serine,  X  amino  acid,  valine  (T/SXV) 
and 4.1/ERM-mediated  protein interactions, while that of 
the 13 domain depends only on 4.1/ERM protein binding. 
Materials and Methods 
hDlg Expression Constructs 
Plasmid constructs were made that expressed various truncations of the 
hDlg cDNA as glutathione-S-transferase (GST) fusion proteins (Fig. 2). 
The appropriate sequences were amplified by polymerase chain reaction 
from human B lymphocyte  sscDNA with oligonucleotide  primers contain- 
ing specific  restriction enzyme sites. The amplified  products were purified, 
digested with restriction enzymes, and ligated into pGEX-S (Pharmacia 
LKB Biotechnology,  Piscataway, NJ) in-frame for expression as GST fu- 
sion proteins in Escherichia coli. All constructs were sequenced for accu- 
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fusion proteins. Various por- 
tions of the hDlg cDNA were 
subcloned  into  pGEX-S  for 
expression  as  NHE-terminal 
fusions with GST. The amino 
acid boundaries of each hDlg 
moiety  and  the  presence  of 
alternatively  spliced  inser- 
tions  are  indicated  for  each 
construct.  All  constructs  in- 
cluded GST at their NHE-ter- 
mini (not shown). 
racy and produced soluble fusion proteins of the expected sizes. The con- 
structs were  also characterized  to determine which alternatively spliced 
insertions they contained: SH3/guanylate kinase constructs with either the 
I2 (GST-SG 12) or I3 (GST-SG I3) domains. The GST-hDIg fusion proteins 
were expressed and purified according to a protocol modified from Smith 
and Johnson (1988) and described elsewhere (Lue et al., 1994). 
Antibodies 
Rabbit polyclonal antibodies 405 and 411  were raised against bacterially 
expressed and purified portions of hDlg from residues 200-960 and 1-200, 
respectively. Rabbit polyclonal antibody 14 raised against human erythro- 
cyte protein 4.1 has been described previously (Lue et al., 1994).  Both an- 
tibodies 405 and 14 were affinity purified by absorption to nitrocellulose 
immobilized antigen as described (Byers et al., 1987).  Rabbit polyclonal 
antibodies 220, 464, 457,  and 454 raised  against peptides  derived from 
ezrin, radixin, and moesin are described and numbered in Winckler et al. 
(1994). 
Binding Assays with Protein 4.1 
N8-4.1(1), an SP6 eukaryotic expression vector containing a cDNA encod- 
ing human B-lymphocyte protein 4.1 (Lue et al., 1994), was expressed in a 
rabbit reticulocyte lysate supplemented with [14C]leucine  according to the 
manufacturer's directions (Promega Corp., Madison, WI). The size of the 
radiolabeled protein 4.1 was verified by SDS-PAGE followed by autora- 
diography. The 14C-labeled protein 4.1 was also purified from the reticulo- 
cyte lysate by immunoprecipitation and digested to completion with an 
excess of ct-chymotrypsin. The labeled digestion products were resolved 
by tricine SDS-PAGE with a continuous gradient from 10-16% polyacryl- 
amide followed by autoradiography. The sizes of the digestion products 
(30, 16, and 10 kD) matched those predicted for the native protein (Leto 
and Marchesi, 1984). This implied that the expressed protein 4.1 was prop- 
erly folded and suitable for use in the binding assays. 
The fusion proteins (Fig. 2) were produced and purified as described 
(Lue et al., 1994)  and subsequently immobilized on glutathione agarose 
beads in binding buffer containing 120 mM KCI, 5 mM sodium phosphate, 
pH 7.6,  1.0 mM 13-mercaptoethanol, and 0.5 mM EDTA. The ratio of fu- 
sion protein to beads was normalized to 0.2 i~g/p~l  packed beads for all of 
the hDlg constructs. 5 ILl of reticulocyte lysate containing 14C-labeled 4.1 
was added to 30 ~l packed beads and incubated at 4°C for 90 min with 
gentle mixing. Each binding assay included 10-20 mg/ml of nonspecific 
blocking proteins from the reticulocyte lysate. The beads were then exten- 
sively washed with binding buffer and aspirated dry. Bound 14C-labeled 
4.1 was released in hot SDS sample buffer and resolved by SDS-PAGE 
for  autoradiography.  Control  assays were  performed  with  double  the 
amount of GST alone immobilized on beads. To test for specificity, com- 
petitive assays were also performed in the presence of a 10-fold molar ex- 
cess of the unlabeled 30-kD 4.1 domain purified from human erythrocytes 
as described (Lue et al., 1994). 
Structural Mapping of the PDZ1-2 Domain 
Full-length and various truncations of the PDZ1-2 fusion protein were 
cleaved away from GST as described (Lue et al., 1994).  After anion ex- 
change fast protein liquid chromatography purification, the PDZ moieties 
were dialyzed into digestion buffer containing 20 mM Tris-HC1, pH 7.5, 
and 50 mM NaCl for a-chymotrypsin, or 20 mM Tris-HCl, pH 8.0, 13 mM 
NaCl, 1 mM DTT, and 1 mM CaCl  2 for trypsin. The proteins at 0.5 mg/ml 
were then digested at room temperature with a-chymotrypsin or trypsin 
(Sigma Chemical Co., St. Louis, MO) at an enzyme to substrate molar ra- 
tio of 1:200 or 1:100, respectively. Samples were taken at several time in- 
tervals between t  =  0 and t  =  120 min and immediately boiled in SDS- 
sample buffer. Equal  loadings of the digestion products normalized by 
protein concentration were resolved by SDS-PAGE. 
The SDS-polyacrylamide gels containing the resolved digestion prod- 
ucts  were  electroblotted  onto  poly(vinylidene  difluoride)  membranes 
(BioRad Labs, Hercules, CA). The protease digestion products were then 
excised from the blot and sequenced on protein sequencer (model 470A; 
Applied Biosystems Inc., Foster City, CA) with an on-line phenylthiohy- 
dantoin analyzer (model 120A; Applied Biosystems, Inc.). The NH2-ter- 
minal 10 amino acids were identified for each digestion product. The mo- 
lecular  weights  of  selected  digestion  products  were  determined  by 
electrospray ionization mass spectrometry performed on a triple quadru- 
pole mass spectrometer (Finnigan TSQ700; Microchemistry Facility, Har- 
vard University, Cambridge, MA). 
Coimmunoprecipitation 
35S-labeled  extracts from murine NIH-3T3 cells were prepared from ~5 × 
107 plated cells that were washed three times in 37°C PBS and then precul- 
tured for 4 h in 25 ml DME lacking Met and Cys, supplemented with 10% 
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protein  4.1-binding  site 
within  the  PDZ  domain  of 
hDlg. taC-labeted protein 4.1 
was  incubated  with  various 
GST-hDlg  fusion  proteins 
immobilized  on  beads.  The 
beads  were  sedimented  and 
washed as described in Mate- 
rials  and Methods.  Autorad- 
iograms  of  the  SDS-PAGE 
resolved  laC-labeled  protein 
4.1  in  the  supernatant  (lane 
1) and bead pellet (lanes 2-5) are shown. The immobilized hDlg 
fusion protein  used in  each  case  is indicated  above  each  lane. 
The positions of the intact protein 4.1 polypeptide  (65 kD)  and 
its 30-kD breakdown product are indicated by arrowheads. 
dialyzed FBS and 1 mM L-glutamine. 2.5 mCi of 3~S-labeled  Met and Cys 
was added to the medium and the incubation continued for another 4 h. 
The metabolically labeled cells were washed three times in cold TBS and 
lysed in TBS containing 1% NP-40, 10% glycerol, 2 mM EDTA, 2 Ixg/ml 
leupeptin, 1 mM Pefabloc SC, 0.5 p,M aprotinin, and 1 p,M pepstatin. The 
dishes were rocked gently on ice for 30 min, and the remaining cells were 
detached with a rubber policeman. The crude lysate was clarified at 16,000 g 
at 4°C for 30 min and the supernatant was either used immediately or 
flash frozen in  ethanol/dry ice  and stored  at  -70°C.  Lysates were  ex- 
tensively precleared with preimmune rabbit serum followed by protein 
A-Sepharose before use. In competition assays, the precleared cell lysate 
was supplemented with purified PDZ1-2 and SG  13 polypeptides at a final 
concentration of 250 ~g/ml. For each assay, 100 ~1 of precleared lysate 
was incubated with 10 Ixl anti-hDlg affinity purified antibody (405 or 411) 
on ice for 2 h. Antibody 411 was used in the competition assays because it 
immunoprecipitates only full-length endogenous hDlg and not the PDZ1-2 
and  SG  13  polypeptides.  The  immune  complexes  were  collected  on 
Sepharose beads conjugated to 50 tzg protein A  and washed four times 
with ice cold lysis buffer. The radioactive proteins were resolved by SDS- 
PAGE and blotted to nitrocellulose. The blots were then either exposed 
to film or probed with various antibodies. Complexes isolated from 3T3 
cells were probed with polyclonal antibodies against human protein 4.1 
(14), an epitope shared by ezrin, radixin, and moesin (220), and epitopes 
unique to either ezrin (464), radixin (457), or moesin (454). 
SubceUular Targeting of hDlg Fusion Proteins 
Our method was partly based on techniques used to study protein trans- 
port into the nucleus and Golgi complex (Beckers et al., 1987; Goda and 
Pfeffer, 1989; Adam et al., 1990; Moore and Blobel, 1992). Cryosections of 
normal human colon epithelia were prepared on glass slides. Unfixed hu- 
man tissues were  kindly provided by Youbin Wang and Lan Bo  Chen 
(Harvard Medical School, Boston, MA). Small pieces of tissue were rap- 
idly frozen in isopentane and stored in liquid nitrogen before cryosection- 
ing. 5-10 p,m sections were cut in a cryostat, captured on glass slides, and 
air dried. Frozen tissue sections were thawed at room temperature in PBS 
before use. CX-1 cells were grown on glass coverslips and washed twice 
with PBS before use. Cells from both types of preparation were subse- 
quently washed twice in targeting buffer (TB) containing 40 mM Hepes 
acetate, pH 7.5, 5 mM magnesium acetate, 150 mM potassium acetate, 1 
mM EGTA, 10% sucrose, 1% newborn calf serum NCS,  2 mM Pefabloc, 4 
~M leupeptin, and 2 ~LM pepstatin. The cells were then permeabilized in 
TB with a final concentration of 75 p.M digitonin for 30-60 s at room tem- 
perature. The permeabilized cells were washed twice in fresh TB and then 
overlaid with TB supplemented with GST-hDIg fusion protein at a final 
concentration of 10-50 gg/ml. In competition experiments, the GST-hDlg 
fusion proteins were preincubated for 2 h before addition to the cells with 
a 10-fold molar excess of either the native 30-kD protein 4.1 domain (250 
pLg/ml) or an 11-amino acid peptide (CSNAKAVETDV) derived from the 
COOH-terminus of the Shaker-type K ÷ channel (12 l~g/ml). After a 1 h in- 
cubation with fusion protein at room temperature, the cells were  washed 
three times with fresh TB and excess liquid removed from the coverslip. The 
cells were then fixed in 100% methanol at -20°C for at least 10 rain. 
Fixed cells were rinsed twice in PBS, then overlaid with PBS containing 
a  1:200 dilution of affinity purified rabbit anti-GST polyclonal antibody 
(385),  1% Tween-20, and 1% BSA, and incubated for I  h  at 37°C.  The 
rabbit  anti-protein 4.1  polyclonal antibody (14)  and a  mouse anti-GST 
mAb (Santa Cruz Biotechnologies, Santa Cruz, CA) were substituted for 
385  in  all  double-label  experiments. The cells were  then washed three 
times in PBS/Tween and overlaid with PBS/Tween containing a 1:250-400 
dilution of either FITC-conjugated goat anti-rabbit  IgG  (Zymed Labs, 
Inc., S.  San Francisco, CA), FITC-conjugated goat anti-mouse IgG, or 
rhodamine-conjugated goat anti-rabbit IgG (Southern Biotechnology As- 
sociates, Inc., Birmingham, AL) and 1% BSA and incubated at 37°C for 
30 min. The cells were then washed twice in I'BS and twice in distilled wa- 
ter. Excess liquid was removed from the coverslip or slide before mount- 
ing in SlowFade glycerol medium (Molecular Probes, Eugene, OR). FITC 
and rhodamine fluorescence patterns were visualized in optical sections 
taken with a confocal microscope (model M600; BioRad Labs). Four inde- 
pendent preparations of cells or tissue were examined for each applied fu- 
sion protein. 250 cells total were counted from five microscope fields per 
preparation, and the number of cells with detectable immunofluorescence 
Figure 4.  The PDZ1-2 inter- 
repeat  sequence  is  con- 
served  in  a  subset  of 
MAGUK  proteins.  Several 
group  I  MAGUK  proteins 
(Fig.  1)  contain  the  closely 
juxtaposed  pair  of  PDZ  re- 
peats with a  pattern  of posi- 
tively  charged  residues  be- 
tween  the  two  repeats 
(highlighted  in  black).  This 
pattern is also found in the I3 
domain of hDlg. 
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or  free  13  domain  compete 
with  bead  bound  PDZ1-2C 
for  binding  to  protein  4.1 
14C-labeled protein  4.1  was 
incubated  with  GST-PDZ1-2 
fusion  protein  on  beads  in 
the presence of a 10-fold mo- 
lar  excess  of  the  indicated 
free polypeptides.  The beads 
were sedimented and washed 
as described  in Materials  and 
Methods.  Autoradiograms 
of the  SDS-PAGE resolved 
14C-labeled protein 4.1 in the 
supernatant  (lane  1)  and 
bead pellets  (lanes  2-4)  are 
shown.  Molecular  masses  in 
kD are indicated on the right. 
specificity  of any  observed  binding  using  the  expressed 
protein was confirmed by competition with the native hu- 
man erythroid 30-kD protein 4.1 domain (data not shown). 
Our results map protein 4.1-binding to the hDlg domain 
comprised of PDZ repeats 1 and 2 (Fig. 3). No binding ac- 
tivity was detected with any of the PDZ repeats in isola- 
tion. Since both the PDZ1-2 domain and the 13 domains 
have protein 4.1-binding activity, we compared their amino 
acid  sequences  and  found  a  distinctive  pattern  of posi- 
tively charged residues  in  the  region between the  PDZ1 
and PDZ2 repeats that was also present in the 13 domain 
(Fig. 4). As expected from the similar pattern of charged 
residues in the PDZ1-2 and 13 domains, both appeared to 
bind to the same site on protein 4.1.  A  10-fold molar ex- 
cess of free SG  I3 polypeptide (Fig. 2)  competed with the 
PDZ1-2 domain for binding to protein 4.1 (Fig. 5). The site 
on protein 4.1 to which hDlg binds was previously mapped 
to the 30-kD NH2-terminal domain (Lue et al., 1994). 
at intercellular junctions was noted. Thus, a total of 1,000 cells were 
counted for each experimental  condition. 
Results 
PDZ1-2 Binds to Protein 4.1 
To determine if a site for protein 4.1 binding was localized 
to a  specific PDZ repeat, various GST-PDZ fusion pro- 
teins immobilized on glutathione agarose beads were incu- 
bated with  14C-labeled protein 4.1  and  then  sedimented. 
The decision to use reticulocyte-expressed protein 4.1  in 
our binding  assays was based  on  experimental compari- 
sons with E. coli expressed protein and the native protein 
purified from human erythrocytes.  Bacterially expressed 
protein  4.1  was insoluble  and  thus  unsuitable  for use in 
binding assays. Native protein 4.1,  which we have used in 
previous work (Lue et al., 1994), was prone to nonspecific 
aggregation  1-2  wk  after  purification.  In  contrast,  the 
reticulocyte-expressed protein 4.1  could be stored  in the 
lysate at  -20°C for up to 9 mo without signs of aggrega- 
tion or loss of activity. Proper folding of this protein was 
verified by oL-chymotrypsin digestion  (see  Materials  and 
Methods), and the NH2-terminal 30-kD domain displayed 
the  protease  resistance  of  a  well-folded  structure.  The 
PDZ1-2 Forms a Single Conformational and 
Functional Unit 
Our observations suggested that the binding site for pro- 
tein  4.1  within  the  PDZ1-2  domain  encompassed  the 
boundary between the two repeats. Since the end of PDZ1 
and  the  beginning  of PDZ2  defined  by sequence  align- 
ment were separated by only eight residues, we hypothe- 
sized that the first two repeats in fact formed a single func- 
tional domain with a  folded structure that spanned both. 
This also suggested that the  PDZ repeat boundaries  de- 
fined by sequence  alignment might not coincide with the 
boundaries of well-folded structural  units.  Because there 
are many potential ct-chymotrypsin and trypsin sites dis- 
tributed within  the  PDZ1-2 sequence  (Fig. 6),  we tested 
the stability of the PDZ1-2 domain in the presence of ei- 
ther protease (Fig. 7 A). The results showed that PDZ repeats 
1 and 2 together form a single stable structure that included 
all of the PDZ sequences defined by amino acid alignment. 
In fact, our determination of the NH2-terminal amino acid 
sequence together with the molecular weight of the PDZ1-2 
digestion  product  showed  that  the  only ct-chymotrypsin 
cleavages that occurred lay downstream of the predicted 
COOH-terminal PDZ2 boundary (Fig. 7 A).  Several po- 
tential  a-chymotrypsin  sites  upstream  of  the  predicted 
Figure 6.  Comparative sequence  alignment and protease map of the domain formed by PDZ Repeats 1 and 2. The amino acid sequence 
of PDZ1-2 from hDlg is aligned with that of PDZ1-2 from Drosophila Dig, rat PSD-95, and human ZO-1. Conserved residues are high- 
lighted in grey, and potential c~-chymotrypsin and trypsin sites for hDlg are indicated above its sequence. 
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unit (PDZ1-2) that includes all of both repeats. Purified PDZ1-2 
peptide was dialyzed into the appropriate enzyme buffer and di- 
gested at room temperature with a-chymotrypsin or trypsin at the 
indicated enzyme to substrate molar ratios. Samples were taken 
at the time intervals noted and resolved by SDS-PAGE. Diges- 
tion products were also gel purified and subjected to NH2-termi- 
nal amino acid sequencing and molecular weight determination 
by mass spectrometry to define the  new boundaries  of the  di- 
gested  peptides.  Potential  protease  cleavage  sites  are  dia- 
grammed below each gel.  Sites  sensitive  to digestion are indi- 
cated by a pair of scissors  and the appropriate residue numbers. 
Molecular masses in kD are indicated on the left.  (A) Digestion 
of PDZ1-2 with tx-chymotrypsin  and trypsin. (B) Digestion of the 
PDZ1-2C  peptide  with  c~-chymotrypsin.  The  boundaries  of 
PDZ1-2C  are  those  of the  PDZ1-2  a-chymotrypsin digestion 
product. 
PDZ1  boundary were  resistant  to digestion,  and  the  se- 
quence  containing  these  potential  sites  must  also  be  in- 
cluded in the stable fold of the PDZ1-2 domain. Sequence 
alignment  shows that  several of the large MAGUK  pro- 
teins  have conserved many of these  residues  (Fig. 6).  As 
expected, a PDZ1-2C peptide that had the boundaries de- 
rived from the PDZ1-2 digestion product was resistant  to 
c~-chymotrypsin digestion (Fig. 7 B). After 90 min of diges- 
tion at room temperature,  >85% of PDZ1-2C was still in- 
tact as determined by gel densitometry. 
To  confirm  that  the  entirety  of both  repeats  was  re- 
quired for the structural integrity of PDZ1-2, we digested 
peptides that contained all of PDZ1 with an NH2-terminal 
portion of PDZ2 (PDZI-1/2), all of PDZ2 with a  COOH- 
terminal portion of PDZ1 (PDZ 1/2-2), and a COOH-ter- 
minal portion  of PDZ1  with  an NH2-terminal  portion of 
PDZ2 (PDZ 1/2-1/2).  The boundaries  of all the digestion 
products were determined as described above for PDZ1-2. 
Figure  8.  The stability  of the  PDZ1-2 conformational unit  re- 
quires  all  of both PDZ repeats.  Purified peptides  with various 
truncations of the PDZ1-2C conformational unit were subjected 
to oL-chymotrypsin digestion as described.  NHz-terminal amino 
acid determination and mass spectrophotometry, when required, 
were used to define c~-chymotrypsin sites  sensitive  to digestion. 
Potential protease cleavage sites are diagrammed below each gel. 
Sites sensitive  to digestion are indicated by a pair of scissors and 
the appropriate residue numbers. Molecular masses in kD are in- 
dicated  on the  left.  (A)  Digestion of PDZI-1/2 (the  complete 
PDZ1 repeat with the NH2-terminal half of PDZ2).  (B) Diges- 
tion of PDZ1/2-2 (the complete PDZ2 repeat with the COOH- 
terminal  half  of  PDZ1).  (C)  Digestion  of  PDZ1/2-1/2  (the 
COOH-terminal  half of PDZ1  with  the  NH2-terminal  half of 
PDZ2). 
In the case of PDZI-1/2 and PDZ 1/2-2, digestion occurred 
only at  potential  a-chymotrypsin sites  within  the  incom- 
plete  repeat  (Fig.  8, A  and  B).  The  single,  complete  re- 
peats in PDZI-1/2 and PDZ 1/2-2 were entirely stable.  In 
contrast,  PDZ  1/2-1/2  appeared  to be unstructured  since 
digestion occurred at  all of the potential  et-chymotrypsin 
sites (Fig. 8 C). Since PDZ1 and PDZ2 individually folded 
into stable structures,  the stability of PDZ1-2 represented 
a higher order folding or packing of the two repeats. 
To relate  the higher  order structural  fold of PDZ1-2 
to its ability to bind protein 4.1, we tested the PDZI-1/2, 
PDZ 1/2-2, and PDZ 1/2-1/2 peptides for binding activity. 
Although all three of the truncated PDZ polypeptides in- 
cluded the complete pattern of interrepeat residues found 
in  PDZ1-2,  only  full-length  PDZ1-2  bound  protein  4.1 
(Fig.  9).  Although  the  polypeptides  used  in  each  assay 
were shown to be intact by SDS-PAGE (data not shown), 
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PDZ1-2 conformational unit 
is  required  for  protein  4.1 
binding.  14C-labeled  protein 
4.1 was incubated with vari- 
ous  GST-PDZ  fusion  pro- 
teins  on  beads.  The  beads 
were sedimented and washed 
as described in Materials and 
Methods.  Autoradiograms 
of the  SDS-PAGE resolved 
14C-labeled protein 4.1 in the 
supernatant  (lane  1)  and 
bead pellets (lanes 2-5) are shown. The immobilized fusion pro- 
tein is indicated above each lane. 
priate  size for an alternatively  spliced isoform of protein 
4.1 (Conboy et al., 1991). The 85-kD isoform of protein 4.1 
also coprecipitated with hDlg from human MCF-7 cell ly- 
sates (data not shown). The distinctive 75-kD protein dou- 
blet  present  in  the  immune  complex  precipitated  from 
NIH-3T3  cells  was  recognized  by  an  antibody  raised 
against an epitope shared by all the ERM family members 
(Fig. 10 A, lane 2), consistent with there being at least two 
the mere presence of the interrepeat  residues was clearly 
not sufficient for binding. Rather,  the higher order struc- 
ture of PDZ1-2 was required for protein 4.1-binding activ- 
ity, and only this structure must present the site in a man- 
ner suitable for binding. 
hDlg, Protein 4.1, and Ezrin Are Part of a 
Multiprotein Complex 
Since both sites on hDlg bind to the 30-kD NH2-terminal 
domain  of protein  4.1  that  is  the  most  conserved  motif 
across a  family of proteins  (Rees  et  al.,  1990),  we tested 
whether  other 4.1/ERM  family members  might associate 
with hDlg in cells. A  complex consisting of several distinct 
polypeptides (115, 110, 85, and 75 kD) was immunoprecip- 
itated from murine NIH-3T3 cells by anti-hDlg antibodies 
(Fig.  10 A). Those  at  115  and  110 kD were identified  as 
murine homologues of hDlg using two different polyclonal 
antisera  (data not shown). The 85-kD protein was recog- 
nized by the anti-protein 4.1 antibody and was the appro- 
Figure 10.  Immunoprecipita- 
tion  of  a  protein  complex 
containing hDlg, protein 4.1, 
and  ezrin  from murine  3T3 
cells.  (A)  35S-labeled lysates 
from murine  3T3 cells  were 
immunoprecipitated  with 
anti-hDlg antibody, 405. The 
isolated  immune  complex 
was resolved by SDS-PAGE 
and blotted to nitrocellulose. 
An  autoradiogram  of  the 
blotted  proteins  is shown in 
lane  1.  Parallel  strips  were 
cut from the  same  blot  and 
probed  with  antibodies 
against an epitope conserved 
in  all  ERM  proteins,  220 
(lane 2),  ezrin, 464  (lane 3), 
radixin,  457  (lane  4),  and 
moesin,  454  (lane  5).  (B) 
Anti-hDlg immunoprecipita- 
tions were performed in the 
presence  of  the  competitor 
peptides indicated below (see Materials and Methods). Individ- 
ual lanes from Western blots of the isolated immune complexes 
were cut in half and each portion was probed with either anti- 
ERM antibody 220 or anti-protein 4.1 antibody 14 as indicated. 
Figure 11.  The PDZ1-2 and I3 domains are independently suffi- 
cient for proper intracellular targeting. Colon tissue  cryosections 
were  permeabilized  with  digitonin  under  conditions  that  pre- 
served cell-cell contact structures.  The permeabilized prepara- 
tions were treated  with  exogenous GST-hDIg fusion proteins. 
The localization of bound fusion protein was visualized  with anti- 
GST antibodies followed by FITC-conjugated IgG. Optical sec- 
tions were taken on a scanning confocal microscope. The applied 
fusion protein is indicated at the right of each panel. In A and B, 
arrow heads indicate basal membrane domains and arrows indi- 
cate apical membrane domains. 
Lue et al. Subcellular  Targeting of hDlg  1131 Figure 12.  Exogenous PDZ1-2 and I3 domains colocalize with protein 4.1 in CX-1 cells. Human CX-1 cells were permeabilized and 
treated with exogenous  GST-hDlg fusion proteins as described in the Materials and Methods. The localization of the fusion proteins 
was visualized using a mouse anti-GST mAb followed by FITC-conjugated goat anti-mouse IgG. The colocalization of endogenous pro- 
tein 4.1 was visualized using a rabbit anti-protein 4.1 polyclonal antibody followed by rhodamine-conjugated goat anti-rabbit IgG. Op- 
tical sections at both fluorescence wavelengths were taken on a scanning confocal microscope. 
interacting  members of the  ERM  subfamily in  the  com- 
plex. Indeed, most ERM proteins are of similar size and 
tend  to  resolve  as  75-80-kD  bands  by  SDS-PAGE 
(Winckler et al., 1994).  One of the 75-kD bands was also 
recognized by an ezrin-specific antibody (Fig.  10 A, lane 
3).  Specific  antibodies  against  moesin  (454)  and  radixin 
(457) failed to recognize any of the proteins from the NIH- 
3T3 precipitates (Fig. 10 A, lanes 4 and 5). 
To confirm that both protein 4.1 and the ERM proteins 
were  interacting  with  the  same  sites  on  hDlg,  we  per- 
formed the immunoprecipitation assays in the presence of 
purified PDZ1-2 and SG  I3 polypeptides. Since neither of 
these  polypeptides are recognized by the  anti-hDlg anti- 
body used in these experiments, PDZ1-2 or SG  j3 would be 
expected to compete with endogenous hDlg for binding sites 
on protein 4.1  and  the  ERM proteins.  Such competition 
would result in the coprecipitation of reduced amounts of 
protein 4.1  and the ERM proteins. The PDZ1-2 and SG  13 
polypeptides  individually  excluded  protein  4.1  and  the 
ERM proteins from the hDlg immune complex (Fig. 10 B). 
These data implied that both ERM proteins, one of which 
was ezrin, interacted at the same sites on hDlg as protein 
4.1. The association of the ERM proteins with hDlg in the 
immune  complex  was  most  likely  a  direct  one  because 
there were no other proteins in the complex at stochiomet- 
ric levels besides protein 4.1 (Fig. 10 A, lane 1). While the 
formation of heterodimers between the various ERM pro- 
teins has been observed (Gary and Bretscher, 1995), there 
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Localization at 
intercellular  junctions 
(percentage of total cells) 
Fusion protein  Ceils  Tissue 
GST-NT  6  3 
GST-PDZ 1-2  97  79 
GST-PDZ 1  3  6 
GST-PDZ2  18  16 
GST-PDZ3  5  3 
GST-SG  12  4  8 
GST-SG  13  95  88 
GST alone  2  1 
Four independent cell or tissue preparations were probed with the indicated GST- 
hDlg fusion proteins. Localized exogenous fusion protein was visualized by inununo- 
fluorescence as described. 250 cells total from five microscope fields were counted in 
each preparation, and the total number of cells per preparation with detectable fluo- 
rescent staining at intercellular junctions was determined. Each value represents the 
average percentage out of a total of 1,000 cells with detectable intercellular junction 
staining. Standard deviations ranged from 0.5 to 3%. 
is no evidence for the direct association of ezrin with pro- 
tein 4.1. 
PDZ1-2 and 13 Are Independently Sufficient for 
Subcellular Targeting 
Given the submembrane colocalization of hDlg and pro- 
tein 4.1  at sites of intercellular contact (Lue et al., 1994), 
we tested whether the known protein 4.1-binding domains 
on hDlg were sufficient for targeting to these sites. Tissue 
and cultured cells were permeabilized and treated with ex- 
ogenous GST-hDlg fusion proteins. Successful subcellular 
targeting of the fusion proteins was ascertained using anti- 
GST antibodies  followed by FITC-conjugated IgG. GST 
fusion proteins were chosen as probes because of their sta- 
bility and the signal amplification due to the formation of 
GST dimers in solution.  Several permeabilization condi- 
tions with Triton X-100 and digitonin were tested before 
selecting  a  procedure  that made it possible to introduce 
exogenous  protein  without  any  apparent  disruption  of 
cell-cell  contact  as  determined  by microscopic observa- 
tion. Cryosections of human colon epithelia and CX-1 co- 
lon carcinoma cells were permeabilized with digitonin in a 
buffer (see Materials and Methods) that minimized the os- 
motic disturbance of cellular morphology. 
Exogenous  GST-PDZ1-2  and  GST-SG  I3  specifically 
localized to regions of intercellular contact in colon epi- 
thelial tissue and CX-1 cells (Fig. 11, A  and B; Fig. 12, A 
and  C).  In the  case  of epithelial  tissue,  localization  was 
confined  to  basolateral  membrane  domains.  Exogenous 
GST,  GST-NT,  GST-PDZ1,  GST-PDZ3,  and  GST-SG  12 
failed to display significant localization to any subcellular 
structures  in  either  type  of  preparation.  GST-PDZ2 
weakly localized  to intercellular junctions  in  16-18%  of 
the cells counted. In contrast, GST-PDZ1-2 and GST-SG  I3 
were localized to intercellular junctions in 79 to >95%  of 
the cells counted (Table I). This implied that the PDZ1-2 
and I3 domains were independently sufficient for proper 
targeting to regions  of cell-cell contact.  Moreover,  both 
domains were also sufficient to account for the specific ba- 
solateral  targeting  in  tissue  epithelia,  hDlg  is  the  only 
MAGUK protein known to localize at basolateral mem- 
brane domains. The failure of GST-SG  I2 to correctly local- 
ize suggested that the SH3 domain was not involved in the 
targeting of hDlg to the cytoskeletal structures preserved 
in our assays. Double-label immunostaining showed that 
the localization of endogenous protein 4.1  in the perme- 
abilized CX-1 cells was the same as that of the exogenous 
PDZ1-2 and 13 domains (Fig. 12, B and D). Furthermore, 
endogenous  spectrin  immunostaining  in  permeabilized 
cells was localized  at the plasma membrane, which con- 
firmed that the submembrane cytoskeleton was largely in- 
tact (data not shown). No GST immunostaining was de- 
tected  in  unpermeabilized  ceils  treated  with  exogenous 
fusion proteins (data not shown). 
Competition  experiments  showed  that  localization  of 
the PDZ1-2 domain depended  on two types of protein- 
protein  interaction.  The  T/SXV-containing  K ÷  channel 
peptide,  which  has  been  shown  to  bind  PDZ2  in  hDlg 
(Kim et al., 1995), did not significantly compete for PDZ1-2 
targeting (Fig. 13 A), while the 30-kD protein 4.1  domain 
only weakly competed for PDZ1-2 targeting (Fig. 13 C). In 
contrast,  when  the  competitors  were  applied  together, 
PDZ1-2 did not target to cell-cell contact sites in  CX-1 
cells (Fig.  13  E). Therefore, both 4.1/ERM  protein and 
T/SXV-dependent mechanisms played a role in the subcel- 
lular targeting of PDZ1-2. On the other hand, the 30-kD 
domain of protein 4.1 effectively competed for the subcel- 
lular targeting of the 13 domain (Fig. 13 D). Therefore, 13 
domain targeting depended solely on a 4.1/ERM protein- 
dependent mechanism. 
Discussion 
Our data indicate that the targeting of hDlg to the mem- 
brane cytoskeleton is dependent on PDZ repeats 1 and 2 
and the 13 domain. Although SH3 domains are known to 
bind  polyproline  motifs  found  in  many  signaling  mole- 
cules, and the SH3 domain of phospholipase C-~ is essen- 
tial for targeting to the actin cytoskeleton (Bar-Sagi et al., 
1993), the SH3 domain of hDlg is not essential for mem- 
brane targeting in our assay system. 
All of the MAGUK proteins known contain from one to 
three ~100-amino acid PDZ repeats. Conserved PDZ re- 
peats have also been found in several proteins that are not 
members of the MAGUK family, such as syntrophin and 
the  family of protein  tyrosine  phosphatases  typified  by 
PTP-BAS (for review see Ponting and Phillips, 1995).  Our 
demonstration that the PDZ-protein 4.1-binding interac- 
tion requires the entirety of both PDZ1 and PDZ2 is con- 
sistent with the fact that both repeats together form a sin- 
gle  higher-order  conformational  unit.  The  observation 
that PDZ1-2 is able to target to sites of intercellular con- 
tact far more efficiently than PDZ2 alone further supports 
the notion that the higher-order structure of PDZ1-2 has a 
functional  role.  Although  recent  data  shows  that  single 
PDZ  repeats  can  bind  to  several  membrane  receptors 
(Kim et al., 1995; Kornau et al., 1995; Sato et al., 1995) and 
to the APC tumor suppressor protein (Matsumine et al., 
1996), the K ÷ channel binds more strongly to the PDZ1-2 
sequence than to PDZ2 alone (Kim et al., 1995). While the 
K ÷ channel-binding site is fully contained within  PDZ2, 
the higher-order structure of PDZ1-2 may present the site 
more appropriately for binding to the channel. 
Lue et al. Subcellular Targeting ofhDlg  1133 Figure 13.  Types of protein interactions  involved in the intracellular  targeting of the PDZ1-2 and 13 domains. Permeabilized CX-1 cells 
were treated with exogenous  GST-hDlg fusion proteins that were preincubated with the indicated  competitor peptides (see Materials 
and Methods). The localization of bound fusion protein was visualized with anti-GST antibodies followed by FITC-conjugated IgG. Op- 
tical sections were taken on a scanning confocal microscope. 
The conservation of protein 4.1-binding activity among 
the PDZ1-2 and 13 sequences of hDlg and the site in p55 
(Marfatia et al., 1995) may depend on the pattern of basic 
residues  common to all three domains since their amino 
acid  sequences  are  otherwise not  homologous.  Homolo- 
gous patterns  of basic residues  also  occur in Drosophila 
Dlg and human DLG2, between the  SH3 and  GUK do- 
mains of their respective proteins. While it remains to be 
determined whether the homologous sites in other MAGUK 
proteins also bind to protein 4.1, conserved 4.1/ERM pro- 
tein-binding  activity  is  likely  to  be  one  mechanism  for 
linking MAGUK proteins to the membrane cytoskeleton. 
The structural presentation of the PDZ1-2- and I3 do- 
main-binding sites for protein 4.1 appear to differ substan- 
tially. In the case of the PDZ1-2 domain, the protein 4.1- 
binding site is part of a well-folded structure that protects 
the peptide backbone from protease digestion. In contrast, 
the  13 domain displays the proteolytic sensitivity charac- 
teristic of a flexible loop (data not shown). The phenome- 
non of a conserved protein binding motif being displayed 
in the context of differing secondary structures is also true 
of the integrin-binding RGD motif (for review see Haas 
and Plow, 1994), where differences in the conformational 
presentation of the RGD motif are thought to result in al- 
tered binding affinity or specificity for integrins (Main et al., 
1992; Haas and Plow, 1994; Krezel et al., 1994).  It will be 
of interest to determine whether the  PDZ1-2 and 13 do- 
mains of hDlg display differences in affinity or specificity 
for members of the  4.1/ERM  family that  depend  on  the 
conformational presentation of the binding site. 
The Journal of Cell Biology, Volume 135,  1996  1134 Figure 14.  Model of possible protein-protein associations within 
an hDlg-dependent complex. Diagramatic  representation of an 
hDlg-dependent  protein complex associated with the membrane 
via interactions  with 4.1/ERM  family members and membrane 
glycoproteins.  Four potential sites for protein-protein interac- 
tions besides the PDZ1-2 and 13 domains are represented. PDZ2 
binds  the cytoplasmic portion of the  Shaker-type  K ÷ channel 
(Kim et al., 1995) and is likely to interact with other channel pro- 
teins with the T/SXV motif (Kornau et al., 1995). T/SXV-contain- 
ing cytoplasmic proteins such as the APC tumor suppressor also 
associate with PDZ2 (Matsumine et al., 1996). PDZ3 is likely to 
participate  in as yet undefined protein-protein interactions  that 
may include homotypic binding to PDZ repeats in other proteins 
(Brenman et al., 1996). The alternatively spliced 11 domain is pre- 
dicted to form a poly-proline II helix and binds SH3 motifs com- 
monly found in both cytoskeletal and signaling proteins (Lue, R., 
unpublished  results). The SH3 motif of hDlg probably binds to 
poly-proline sequences in other signaling molecules. Blot binding 
assays indicate that it does not bind to the poly-proline sequence 
of I1 (Lue, R., unpublished results). 
The fact that ezrin is one of a limited number of proteins 
that coprecipitates with hDlg supports the idea that differ- 
ent but related proteins could bind at hDlg's two protein 
4.1-binding sites. The 30-kD NH2-terminal domain of pro- 
tein 4.1 to which hDlg binds (Lue et al.,  1994) is well con- 
served across a  superfamily of related proteins including 
ezrin (Gould et al., 1989), talin (Rees et al., 1990), the hu- 
man protein tyrosine phosphatase PTPase MEG (Gu et al., 
1991),  and  the  NF2  gene  product,  merlin/schwannomin 
(Rouleau et al., 1993; Trofatter et al., 1993). The associa- 
tion of hDlg with members of the 4.1/ERM family could 
account for its membrane localization since many family 
members  bind  to  integral  membrane  proteins.  Human 
erythrocyte protein 4.1  links the spectrin network to the 
membrane  via  glycophorin  C  (Anderson  and  Lovrien, 
1984; Leto et al., 1986). Ezrin, moesin, and radixin all asso- 
ciate  with  CD44,  a  widely  distributed  140-kD  integral 
membrane glycoprotein (Sato et al.,  1992; Tsukita et al., 
1994), which may represent an alternative way by which 
protein 4.1-related proteins associate with the membrane. 
We  have shown  similar  localization patterns  for human 
protein 4.1  and hDlg  (Lue et al.,  1994), and Drosophila 
protein 4.1 has been localized to septate junctions (Fehon 
et aI.,  1994)  precisely where Dig is located (Woods and 
Bryant, 1991).  This suggests that the interaction between 
MAGUK proteins and members of the 4.1/ERM family is 
functionally relevant in both vertebrates and invertebrates. 
Our results show that the subcellular targeting of hDlg 
depends on several overlapping protein interactions. Sub- 
membrane domains such as those at focal adhesions and 
tight junctions are commonly characterized by large com- 
plexes of cytoskeletal and signaling proteins  (for review 
see Yamada and Miyamoto, 1995; Tsukita et al., 1993). Our 
demonstration that the two 4.1/ERM protein-binding do- 
mains of hDlg, PDZ1-2 and 13, are sufficient for subcellu- 
lar targeting defines one of the important protein-protein 
interactions involved in MAGUK localization. The associ- 
ation of PDZ1-2 with a T/SXV-containing protein repre- 
sents another mechanism for localization. It is noteworthy 
that hDlg colocalizes with the adenomatus polyposis coli 
(APC) tumor suppressor protein at basolateral submem- 
brane domains via just such a T/SXV-mediated interaction 
(Matsumine et al., 1996). It will be of interest to identify 
the single or multiple T/SXV-containing proteins that are 
involved in the PDZ1-2-dependent targeting of hDlg. 
The protein interactions described here could allow for the 
cross-linking of hDlg molecules and their associated pro- 
teins. In one scenario, the bivalent interaction of hDlg with 
4.1/ERM family members could form a physical network 
of hDlg molecules and cross-link associated proteins. Al- 
ternatively, the ability of PDZ1-2 to associate with T/SXV 
motifs while the I3 domain associates with 4.1/ERM pro- 
teins would also allow for the cross-linking of hDlg mole- 
cules.  Thus,  hDlg  (as  well  as  other MAGUK  proteins) 
may have a  role in nucleating protein complexes at  de- 
fined submembrane domains (Fig. 14). This is consistent 
with the involvement of PSD-95 in the proper clustering of 
Shaker-type K ÷ channels  (Kim et al.,  1995).  Membrane 
channels clustered with MAGUK proteins could assemble 
into specific membrane domains via interactions between 
MAGUKs and 4.1/ERM family members. Other data im- 
plies that PSD-95 could also cluster nitric oxide synthase 
with the NMDA receptor by homotypic, PDZ-PDZ bind- 
ing interactions (Brenman et al., 1996). 
Both the composition and localization of a  MAGUK- 
dependent protein complex will depend  on the comple- 
ment of binding domains contained in that specific MAGUK. 
There  are  substantial  variations  in  the  domain  comple- 
ment between  members  of the  different MAGUK  sub- 
groups (Fig. 1) and between alternatively spliced isoforms 
of hDlg.  hDlg contains at least two alternatively spliced 
isoform-dependent protein-binding domains.  The I1  do- 
main  in  the  NH2  terminus  binds  to  SH3  domains  from 
other proteins  (Lue, R.,  unpublished results)  and the 13 
domain binds to protein 4.1  (Lue et al., 1994). This sug- 
gests that various hDlg isoforms can associate with differ- 
ent  groups  of  proteins  and  consequently  have  distinct 
functions. Since PDZ repeats 1 and 2 are structurally and 
functionally distinct from repeat 3, different types of PDZ- 
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and other proteins. Indeed, the fact that various proteins 
contain differing numbers of PDZ repeats may reflect dif- 
ferences in the relative complexity of their protein interac- 
tions. It will be of interest to determine  whether various 
hDlg isoforms  also display subtle differences  in localiza- 
tion based on the presence of both PDZ1-2 and I3 versus 
just PDZ1-2  alone.  Once  targeted  to the membrane  via 
binding to 4.1/ERM family members or T/SXV receptors, 
binding interactions with other proteins at individual PDZ 
repeats, at the SH3 motif, or at the I1 domain are likely to 
either regulate or directly enable hDlg function. 
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